A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.

Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

Vertex Pharmaceuticals Inc. (VRTX) has secured FDA approval for Suzetrigine, an oral, non-opioid, highly selective NaV1.8 pain signal ...

Celebrex (celecoxib) and ibuprofen are both classified as nonsteroidal anti-inflammatory drugs (NSAIDs). Both are commonly ...

Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended for ... and rehabilitative results after perioperative celecoxib administration for total knee arthroplasty.

[1] A case of this drug reaction from celecoxib is reported. A 61-year-old nonatopic woman presented with 15 round, red-brown, edematous, moderately itching patches. Their size varied from 2 to 10 ...

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...

But prostacyclin is made, in part, with the help of Cox-2 enzymes -- the enzymes that drugs like Celebrex block. Blocking only Cox-2 upsets the balance of these enzymes. Levels of prostacyclin go ...